Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 20 de 1.688
Add filters

Year range
Medical Science Monitor Basic Research ; 29, 2023.
Article in English | Web of Science | ID: covidwho-2242780


Background: Due to the COVID-19 pandemic, frontline nurses have experienced psychological problems. However, the de-pression of frontline nurses in Wuhan 6 months after the outbreak of COVID-19 has not been studied ade-quately. The purpose of this study was to investigate the depression of frontline nurses in Wuhan 6 months after the COVID-19 outbreak and to analyze possible risk and protective factors. Material/Methods: Data were collected through Wenjuanxing from 612 frontline nurses in Wuhan national COVID-19-designated hospitals between July 27, 2020, and August 12, 2020. The levels of depression, family functioning, and psy-chological resilience were assessed among frontline nurses in Wuhan with a depression scale, family function scale, and 10-item psychological resilience scale, respectively. The factors associated with depressive symp-toms were identified using the chi-square test and binary logistic regression analysis. Results: A total of 126 respondents were included in the study. The overall prevalence of depression was 25.2%. The need for mental health services was a potential risk factor for depressive symptoms, while family functioning and psychological resilience were potential protective factors. The COVID-19 pandemic poses a major chal-lenge to the depressive symptoms of frontline nursing in Wuhan, highlighting the need for all frontline nurses in Wuhan to be screened for depression regularly for timely intervention. Conclusions: To mitigate the impact of the pandemic on depression, psychological interventions for frontline nurses need to be implemented to preserve their mental health.

Wall Street Journal - Online Edition ; : N.PAG-N.PAG, 2023.
Article in English | Academic Search Complete | ID: covidwho-2241975
Journal of Medical Virology ; 95(1), 2023.
Article in English | Scopus | ID: covidwho-2241186


With increased transmissibility and novel transmission mode, monkeypox poses new threats to public health globally in the background of the ongoing COVID-19 pandemic. Estimates of the serial interval, a key epidemiological parameter of infectious disease transmission, could provide insights into the virus transmission risks. As of October 2022, little was known about the serial interval of monkeypox due to the lack of contact tracing data. In this study, public-available contact tracing data of global monkeypox cases were collected and 21 infector-infectee transmission pairs were identified. We proposed a statistical method applied to real-world observations to estimate the serial interval of the monkeypox. We estimated a mean serial interval of 5.6 days with the right truncation and sampling bias adjusted and calculated the reproduction number of 1.33 for the early monkeypox outbreaks at a global scale. Our findings provided a preliminary understanding of the transmission potentials of the current situation of monkeypox outbreaks. We highlighted the need for continuous surveillance of monkeypox for transmission risk assessment. © 2022 Wiley Periodicals LLC.

WHOIRIS; 2022.
Non-conventional in English | WHOIRIS | ID: grc-754946
WHOIRIS; 2022.
Non-conventional in English | WHOIRIS | ID: grc-754945
WHOIRIS; 2022.
Non-conventional in English | WHOIRIS | ID: grc-754944
WHOIRIS; 2023.
Non-conventional in English | WHOIRIS | ID: grc-754938
WHOIRIS; 2023.
Non-conventional in English | WHOIRIS | ID: grc-754937
WHOIRIS; 2023.
Non-conventional in English | WHOIRIS | ID: grc-754936
WHOIRIS; 2023.
Non-conventional in English | WHOIRIS | ID: grc-754935
Disaster Medicine and Public Health Preparedness ; 17(18), 2023.
Article in English | Scopus | ID: covidwho-2241042


Mass vaccination campaigns have been used effectively to limit the impact of communicable disease on public health. However, the scale of the coronavirus disease (COVID-19) vaccination campaign is unprecedented. Mass vaccination sites consolidate resources and experience into a single entity and are essential to achieving community (herd) immunity rapidly, efficiently, and equitably. Health care systems, local and regional public health entities, emergency medical services, and private organizations can rapidly come together to solve problems and achieve success. As medical directors at several mass vaccination sites across the United States, we describe key mass vaccination site concepts, including site selection, operational models, patient flow, inventory management, staffing, technology, reporting, medical oversight, communication, and equity. Lessons learned from experience operating a diverse group of mass vaccination sites will help inform not only sites operating during the current pandemic, but also may serve as a blueprint for future outbreaks of highly infectious communicable disease. © The Author(s), 2021. Published by Cambridge University Press on behalf of Society for Disaster Medicine and Public Health, Inc.

Environmental Science and Pollution Research ; 30(1):1540-1561, 2023.
Article in English | Scopus | ID: covidwho-2240383


Small- and medium-sized enterprises (SMEs) in China have been hit hard by the coronavirus (COVID-19) outbreak, which has jeopardized their going out of business altogether. As a result, this research will shed light on the long-term impacts of COVID-19 lockdown on small businesses worldwide. The information was gathered through a survey questionnaire that 313 people completed. Analyzing the model was accomplished through the use of SEM in this investigation. Management and staff at SMEs worldwide provided the study's data sources. Research shows that COVID-19 has a significantly bad influence on profitability, operational, economic, and access to finance. In the study's findings, outside funding aids have played an important role in SMEs' skill to persist and succeed through technological novelty than in their real output. SME businesses, administrations, and policymakers need to understand the implications of this study's results. © 2022, The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.